![](/img/cover-not-exists.png)
FEV1 reversibility does not adequately predict effect of formoterol via Aerolizer® in chronic obstructive pulmonary disease
J-F. Muir, D. Benhamou, A. Cuvelier, V. Le Gros, T. Overend, D. Till, G. Della Cioppa, J. KottakisVolume:
58
Year:
2004
Language:
english
Pages:
8
DOI:
10.1111/j.1368-5031.2004.00164.x
File:
PDF, 141 KB
english, 2004